Divi's Laboratories Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 11, 2025
DIVISLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Divi's Laboratories has circulated the notice for its 35th Annual General Meeting (AGM) on August 11, 2025, at 10:00 a.m. IST, to be held via video conferencing. Key items on the agenda include adoption of FY2024-25 audited financial statements and declaration of a dividend of ₹30 per equity share (1,500% on face value of ₹2), subject to shareholder approval. The notice also seeks approval for re-appointment of two retiring directors (Ms. Nilima Prasad Divi and Dr. S. Devendra Rao), appointment of V. Bhaskara Rao & Co. as Secretarial Auditors for five years (FY2025-26 to FY2029-30), and enhancement of remuneration of Mr. Nimmagadda Venkata Anirudh, Head of Nutraceuticals and son of Executive Director Mr. N.V. Ramana, to ₹4,00,000 per month effective September 1, 2025. The record date for dividend eligibility is July 25, 2025, with payment scheduled from August 16, 2025. Remote e-voting will be open from August 7 to August 10, 2025, with the cut-off date set as August 4, 2025.
The ₹30 dividend (1,500%) reflects continued strong shareholder returns from the pharma major. The related-party remuneration approval for a promoter family member is a routine compliance matter; overall, the AGM notice is procedural with no major surprises for investors.